Refine by
Diabetic Ulcer Articles & Analysis
17 articles found
Introduction At R&L Medical, we believe wound care is entering a new era. Traditional bandages and gauze once served as the primary option for wound management, but they often fell short in addressing modern clinical needs. Patients require solutions that not only protect against contaminants but also create an environment where the body can heal efficiently and comfortably. This is where ...
Chitosan is a natural, biodegradable polysaccharide derived primarily from the shells of shrimp, crabs, and fungi. Due to its biocompatibility, antimicrobial properties, and film-forming capabilities, chitosan is widely used in food preservation, water treatment, cosmetics, agriculture, and biomedical applications. 1. What is Chitosan? Chitosan is produced by the deacetylation of chitin, a ...
ByMatexcel
Hundreds of millions of people suffer skin tissue damage every year, including accidental injury, surgical injury, chronic ulcer, etc., and severe cases may lead to amputation or even life-threatening. Suturing is currently the preferred method for clinically closing wounds. However, wound suturing takes a long time during the operation, and removing the stitches will cause secondary damage to ...
Healing rate: 25.3 mm2/day. Healing time: 33 days. Wound size: 38 × 22 × 8 mm. Age of wound when treatment started: > 1 year. Subject: 52/male. Insulin dependent diabetic, peripheral neuropathy, hypertension, renal failure on hemodialysis; history of chronic foot ...
Healing rate: 14.3 mm2/day. Healing time: 103 days. Wound size: 49 × 30 × 3 mm. Age of wound when treatment started: ~ 3 months. Subject: 62/male. Non-insulin dependent diabetes, venous insufficiency, peripheral neuropathy, HTN, CHF, COPD, ...
Patient History Patient is a 40-year-old female with a history of type 2 diabetes. Patient presented to the Emergency Room with a diabetic foot ulcer and infection. The surgeon took the patient to the OR for debridement, drained the infection, and started antibiotics. The patient was treated with advanced modalities that included NPWT and a bioengineered skin substitute. Primary Diagnosis ...
Patient: 65 year old Caucasian male with non-healing diabetic wound on his foot Age of Wound: Greater than 4 years Previous Therapy: 5 months of NPWT Treatment: OxyGeni® set at 3 ml/hr Days on Service: 81 days Outcome: Goals met. Wound healed. High patient satisfaction. Physician Testimony: “In my practice, I see a lot of complicated patients with a multitude of co-morbidities. I ...
Every year, surgeons perform a lower-limb amputation due specifically to diabetes on approximately 73,000 patients in the US alone. Annually there are over 1 million limb amputations worldwide. Most of these amputations are performed for the treatment of non-healing diabetic foot ulcers that resulted from PAD (Peripheral Arterial Disease). These non-healing foot ulcers are caused by high blood ...
As we begin this New Year we have an opportunity to begin with a fresh start as we pursue our passion to promote and speed the healing of wounds! Our role as Wound Care Clinicians has risen to a whole new level of essential care for an extremely high risk population. In this current Covid-19 climate that we are living in, we are all facing challenges that we have never dealt with before. ...
Complex wounds often involve exposed deep structures of the dermal layer, requiring prompt wound closure and tissue reconstruction. It is essential to quickly assess the defect and identify the most effective treatment method for optimizing the patient’s experience and outcome. Often, dermal substitutes are selected as a surgical option for temporizing the wound bed while also facilitating ...
When trauma to the skin occurs, large areas of both the skin’s surface (epidermis) and deeper layers (dermis) may be destroyed. In many cases, large full-thickness wounds may require temporization due to the lack of suitable donor sites for primary skin grafting. Clinical research[1] indicates the temporization of deep, large wounds with dermal scaffolds can not only help provide ...
In a pioneering “off-the-shelf ” drug treatment in place of a surgical procedure, Maruti Hospital on Tuesday inaugurated its Regenerative Medicine Department by administering stem cell therapy for a diabetic patient who lost four toes on both feet. Developed by pharma major, Cipla, in collaboration with Bengaluru-based, Stempeutics Research, over 14 years, it is available (on order) ...
Highlights A retrospective analysis of real-world data published in the ‘International Wound Journal’ compared the wound closure times for diabetic foot ulcers treated with either Endoform™ Natural (1150 wounds) or collagen/ORC (1072 wounds). The data was analyzed to evaluate the median time for wound closure, percentage of wounds healed at 12-,24- and 36- weeks and ...
Many practitioners think about lasers as therapy for various conditions like Fasciitis, Tendonitis, Arthritis, pain and inflammation. Diode lasers are very versatile. Swapping handpieces or adding on attachments to the handpiece allows for increased uses including wounds, ulcers, warts, dermatological conditions like Psoriasis as well as venous insufficiency and fungal ...
Origin, Inc., a Phase III clinical stage biotechnology company, today announced that it has filed a provisional U.S. patent application to enhance the ability of its plasma-generated nitric oxide (NO) antimicrobial and antiviral therapy to be used to treat infections in the respiratory tract and other enclosed spaces in the body. The enhancements are designed to allow Origin’s NO therapy to ...
Origin, Inc., a Phase III clinical-stage biotechnology company, today announced that it had applied to NMPA (formerly CFDA) for classification of its plasma-generated nitric oxide device for the purposes of conducting clinical trials in Hong Kong and mainland China, and that NMPA had accepted its submission. A determination is expected within sixty business days. Origin is in preliminary ...